Evaluation of Whole-Genome Sequence Method to Diagnose Resistance of 13 Anti-tuberculosis Drugs and Characterize Resistance Genes in Clinical Multi-Drug Resistance Mycobacterium tuberculosis Isolates From China
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of Whole-Genome Sequence Method to Diagnose Resistance of 13 Anti-tuberculosis Drugs and Characterize Resistance Genes in Clinical Multi-Drug Resistance Mycobacterium tuberculosis Isolates From China
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-07-31
DOI
10.3389/fmicb.2019.01741
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of the most common embCAB gene mutations associated with ethambutol resistance in Mycobacterium tuberculosis isolates from Iran
- (2019) Azar Dokht Khosravi et al. Infection and Drug Resistance
- Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study
- (2018) Matteo Zignol et al. LANCET INFECTIOUS DISEASES
- Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Association of ubiA mutations and high-level of ethambutol resistance among Mycobacterium tuberculosis Thai clinical isolates
- (2018) Orawan Tulyaprawat et al. TUBERCULOSIS
- A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
- (2017) Paolo Miotto et al. EUROPEAN RESPIRATORY JOURNAL
- Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation
- (2017) Chongguang Yang et al. LANCET INFECTIOUS DISEASES
- A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide
- (2017) Adam N. Yadon et al. Nature Communications
- Molecular Characterization of Prothionamide-Resistant Mycobacterium tuberculosis Isolates in Southern China
- (2017) Yaoju Tan et al. Frontiers in Microbiology
- Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China
- (2017) W. Liu et al. CLINICAL MICROBIOLOGY AND INFECTION
- Genetic Determinants of Drug Resistance inMycobacterium tuberculosisand Their Diagnostic Value
- (2016) Maha R. Farhat et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mutations inpepQConfer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis
- (2016) Deepak Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phylogenetic and Structural Significance of Dihydrofolate Synthase (folC)Mutations in Drug-ResistantMycobacterium tuberculosis
- (2016) Vincent Wing-Sang Cheng et al. Microbial Drug Resistance
- Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study
- (2016) Louise J Pankhurst et al. Lancet Respiratory Medicine
- Identification of novel mutations associated with clofazimine resistance inMycobacterium tuberculosis: Table 1.
- (2015) Shuo Zhang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study
- (2015) Timothy M Walker et al. LANCET INFECTIOUS DISEASES
- Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis
- (2014) R. C. Hartkoorn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Determinants Involved inp-Aminosalicylic Acid Resistance in Clinical Isolates from Tuberculosis Patients in Northern China from 2006 to 2012
- (2014) Xiaobing Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis
- (2014) C. M. Denkinger et al. EUROPEAN RESPIRATORY JOURNAL
- Diagnostic Accuracy of a Molecular Drug Susceptibility Testing Method for the Antituberculosis Drug Ethambutol: a Systematic Review and Meta-Analysis
- (2014) S. Cheng et al. JOURNAL OF CLINICAL MICROBIOLOGY
- A robust SNP barcode for typing Mycobacterium tuberculosis complex strains
- (2014) Francesc Coll et al. Nature Communications
- Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis
- (2014) Wanliang Shi et al. Emerging Microbes & Infections
- Binding Pocket Alterations in Dihydrofolate Synthase Confer Resistance topara-Aminosalicylic Acid in Clinical Isolates of Mycobacterium tuberculosis
- (2013) Fei Zhao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
- (2013) Shuo Zhang et al. Emerging Microbes & Infections
- gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis
- (2012) F. A. Sirgel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection of First- and Second-Line Drug Resistance in Mycobacterium tuberculosis Clinical Isolates by Pyrosequencing
- (2012) Anna Engström et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Dynamic Population Changes in Mycobacterium tuberculosis During Acquisition and Fixation of Drug Resistance in Patients
- (2012) Gang Sun et al. JOURNAL OF INFECTIOUS DISEASES
- Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study
- (2012) Timothy M Walker et al. LANCET INFECTIOUS DISEASES
- Para-Aminosalicylic Acid Acts as an Alternative Substrate of Folate Metabolism in Mycobacterium tuberculosis
- (2012) S. Chakraborty et al. SCIENCE
- Mycobacterium tuberculosis embBCodon 306 Mutations Confer Moderately Increased Resistance to Ethambutol In Vitro and In Vivo
- (2011) Claudia Plinke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutations ingidBConfer Low-Level Streptomycin Resistance in Mycobacterium tuberculosis
- (2011) Sharon Y. Wong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Investigation of Resistance to the Antituberculous Drug Ethionamide in Multidrug-Resistant Clinical Isolates ofMycobacterium tuberculosis
- (2010) F. Brossier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis clinical isolates in the area of Barcelona
- (2010) G. Tudo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular Genetics of para-Aminosalicylic Acid Resistance in Clinical Isolates and Spontaneous Mutants of Mycobacterium tuberculosis
- (2009) V. Mathys et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutations at embB Codon 306 Are an Important Molecular Indicator of Ethambutol Resistance in Mycobacterium tuberculosis
- (2008) A. M. Starks et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started